NEW YORK (GenomeWeb News) – EKF Diagnostics this week said it completed its acquisitions of Selah Genomics and DiaSpect Medical. When the deals were announced last month, EKF said the Selah acquisition comprises an initial consideration of $35.6 million through the issue of new EKF shares and an additional deferred consideration of up to $35 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.